LTFS
ASPX

Ladenburg Thalmann Financial Services’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-48
Closed -$5K – 4913
2015
Q1 		$5K Buy
+48
New +$3.2K ﹤0.01% 4037
2014
Q4 		– Sell
-1,200
Closed -$31K – 4551
2014
Q3 		$31K Buy
1,200
+200
+20% +$4.25K ﹤0.01% 2341
2014
Q2 		$22K Buy
1,000
+500
+100% +$10.9K ﹤0.01% 2613
2014
Q1 		$15K Buy
+500
New +$13.4K ﹤0.01% 2754

Ladenburg Thalmann Financial Services's ASPX Position: Q2 2015 in Review

Ladenburg Thalmann Financial Services sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 48 shares — an estimated $5K sold.

Ladenburg Thalmann Financial Services first reported a position in ASPX in Q1 2014 and held it in 4 quarters. The position peaked at $31K in Q3 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Ladenburg Thalmann Financial Services reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 48 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $5K.
  • Ladenburg Thalmann Financial Services first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 4 quarters.
  • Ladenburg Thalmann Financial Services's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $31K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2015, filed 14 Aug 2015.